Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society.

Keywords — author-chosen ELF test, Fibrotest, NAFLD fibrosis score, Obesity, Transient elastography

MeSH — NLM indexing Germany Guideline Adherence / statistics & numerical data Health Knowledge, Attitudes, Practice Humans Mass Screening / standards Non-alcoholic Fatty Liver Disease / diagnosis Non-alcoholic Fatty Liver Disease / epidemiology Obesity / complications Practice Guidelines as Topic Societies, Medical

Staff actions

Download PDF

Files are for authorised use within BioPredictive partner channels only.

Fibrotest Actitest Article Independent Group Germany

Authors (3)

Petroff D — Clinical Trial Center, University of Leipzig, Leipzig, Germany; IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany.
Blüher M — Department of Medicine, Endocrinology and Nephrology, University of Leipzig, Leipzig, Germany; IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany.
Wiegand J — Clinic of Gastroenterology and Rheumatology, Section of Hepatology, University of Leipzig, Leipzig, Germany; IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany. Electronic address: Johannes.wiegand@medizin.uni-leipzig.de.

Citation

Petroff D, Blüher M, Wiegand J. Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society. Dig Liver Dis. 2018;50(7):731-733. doi:10.1016/j.dld.2018.03.029.

Identifiers

DOI: 10.1016/j.dld.2018.03.029
PMID: 29699861

Tests

Liver diseases

Liver injuries

Comparisons

Subjects

Region

Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society.

More on the same topic

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Three Neglected STARD Criteria Reduce the Uncertainty of the Liver Fibrosis Biomarker FibroTest-T2D in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Toward non-invasive assessment strategies in autoimmune hepatitis.

Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.

Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.